NAWAR MANSOUR
SOUTHAVEN, MS NPI 1720077589
Browse related groups: MS Retrophin, Inc. All categories
General Payments — all program years on this page
$1,151.71
- Category: General Payments
- Program years: PY2018–2024
- Record count: 23
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $58.58 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $58.58 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Retrophin, Inc. | $33.97 | 7 |
| AKEBIA THERAPEUTICS INC | $24.61 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1145834581 | AKEBIA THERAPEUTICS INC | $24.61 | 11/26/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1149888836 | Travere Therapeutics, Inc. | $2.38 | 05/21/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1149888840 | Travere Therapeutics, Inc. | $2.38 | 07/01/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1149888844 | Travere Therapeutics, Inc. | $3.08 | 01/12/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1149888848 | Travere Therapeutics, Inc. | $3.08 | 01/29/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1149888852 | Travere Therapeutics, Inc. | $3.08 | 04/30/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1149888856 | Travere Therapeutics, Inc. | $3.08 | 07/09/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1149888860 | Travere Therapeutics, Inc. | $16.89 | 06/27/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.